ASP Isotopes Inc. Common Stock
NASDAQ:ASPI · NASDAQ Global Market
+$0.32 today
Vol 4.30M · Avg 5.68M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-85.8%
avg -57.8%
ROIC
-11.6%
avg -31.7%
ROA
-34.1%
avg -33.1%
Analysis
ROIC is currently the strongest return metric at -11.6% versus its period average of -31.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Paul Elliot Mann | Executive Chairman & CEO | $1.27M | — | 49 | $9.58M | 11.53% |
Heather Kiessling | Chief Financial Officer | $690,000.00 | — | 61 | $1.55M | 1.86% |
Robert Ainscow | Chief Operating Officer | $638,623.00 | — | 49 | $2.28M | 2.75% |
Hendrik Strydom | Chief Technology Officer | $122,400.00 | — | 65 | $3.80M | 4.57% |
Hendrik T. van Wyk | Head of Engineering | — | — | — | $3.80M | 4.57% |
Stefano Marani | President of Electronics & Space | — | — | 48 | — | — |
Gerdus Kemp | Medical Director & Chief Executive Officer of Pet Labs | — | — | — | — | — |
Donald George Ainscow | EVP, General Counsel & Secretary | — | — | 45 | $2.28M | 2.75% |
Nicholas Michael Mitchell | Co-Chief Operating Officer | — | — | 46 | $117,908.00 | 0.14% |
Xandra van Heerden | Head of Research & Development | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$881,463.71
Sells
23
$9.48M
Net Sentiment
$8.60M
Net selling
Most Active
Ainscow Robert
9 transactions
1–10 of 24
Analysis
Insiders reported 1 buys worth $881,463.71 and 23 sells worth $9.48M over the last 12 months. That adds up to net selling of $8.60M. Ainscow Robert was the most active insider with 9 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +136.3% (6yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +136.3% (6yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
i-80 Gold Corp.
AMEX:IAUX
$1.33B
Oil-Dri Corporation of America
NYSE:ODC
$1.32B
Compass Minerals International, Inc.
NYSE:CMP
$1.27B
Stepan Company
NYSE:SCL
$1.24B
Tronox Holdings plc
NYSE:TROX
$1.22B
Braskem S.A.
NYSE:BAK
$1.19B
United States Antimony Corporation
NYSE:UAMY
$1.15B
Green Plains Inc.
NASDAQ:GPRE
$1.01B
Westlake Chemical Partners LP
NYSE:WLKP
$799.02M
Ferroglobe PLC
NASDAQ:GSM
$707.27M
Who manages ASPI?
ASP Isotopes Inc. Common Stock (ASPI) lists 10 active executives. The top listed executive is Hendrik T. van Wyk, Head of Engineering.
Are ASPI insiders buying or selling?
Recent insider activity shows net buying of $14.35B.
Explore More
Continue the stock analysis
Jump to another research area for this company.